Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Rank	Δ	Cancer	Trial Gap Index (percentile points)	Percentile	Confidence	Sources	Why #n?
1	▲1	Malignant Colon Neoplasm	+51.9	100	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 19731 formula percentile(mortality_count) − percentile(active_trials) activity 225 burdenPercentile 88.9 activityPercentile 37 ranking row 2604221
2	▲1	Malignant Vulvar Neoplasm	+25.9	96.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1347 formula percentile(mortality_count) − percentile(active_trials) activity 54 burdenPercentile 33.3 activityPercentile 7.4 ranking row 2604222
3	▲3	Malignant Uterine Corpus Neoplasm	+14.8	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 6787 formula percentile(mortality_count) − percentile(active_trials) activity 411 burdenPercentile 66.7 activityPercentile 51.9 ranking row 2604223
4	=	Cutaneous Melanoma	+14.8	88.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 2797 formula percentile(mortality_count) − percentile(active_trials) activity 78 burdenPercentile 37 activityPercentile 22.2 ranking row 2604224
4	▲1	Malignant Vaginal Neoplasm	+14.8	88.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 431 formula percentile(mortality_count) − percentile(active_trials) activity 31 burdenPercentile 14.8 activityPercentile 0 ranking row 2604225
6	=	Malignant Ovarian Neoplasm	+14.8	81.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 13445 formula percentile(mortality_count) − percentile(active_trials) activity 684 burdenPercentile 85.2 activityPercentile 70.4 ranking row 2604226
7	▲1	Malignant Bladder Neoplasm	+11.2	77.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4740 formula percentile(mortality_count) − percentile(active_trials) activity 346 burdenPercentile 55.6 activityPercentile 44.4 ranking row 2604227
8	▲1	Malignant Pancreatic Neoplasm	+11.1	74.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 22153 formula percentile(mortality_count) − percentile(active_trials) activity 904 burdenPercentile 92.6 activityPercentile 81.5 ranking row 2604228
9	▲2	Malignant Anal Neoplasm	+7.4	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 806 formula percentile(mortality_count) − percentile(active_trials) activity 68 burdenPercentile 25.9 activityPercentile 18.5 ranking row 2604230
9	▲3	Malignant Laryngeal Neoplasm	+7.4	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 773 formula percentile(mortality_count) − percentile(active_trials) activity 66 burdenPercentile 22.2 activityPercentile 14.8 ranking row 2604229
11	▲2	Malignant Rectal Neoplasm	+3.8	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4491 formula percentile(mortality_count) − percentile(active_trials) activity 386 burdenPercentile 51.9 activityPercentile 48.1 ranking row 2604231
12	▲4	Malignant Kidney Neoplasm	+3.7	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4795 formula percentile(mortality_count) − percentile(active_trials) activity 453 burdenPercentile 59.3 activityPercentile 55.6 ranking row 2604232
13	▲4	Malignant Breast Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 42280 formula percentile(mortality_count) − percentile(active_trials) activity 2627 burdenPercentile 96.3 activityPercentile 96.3 ranking row 2604233
13	▲4	Malignant Lung Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 64743 formula percentile(mortality_count) − percentile(active_trials) activity 2644 burdenPercentile 100 activityPercentile 100 ranking row 2604234
13	▲15	Malignant Thyroid Gland Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1090 formula percentile(mortality_count) − percentile(active_trials) activity 176 burdenPercentile 29.6 activityPercentile 29.6 ranking row 2604235
16	▲5	Malignant Salivary Gland Neoplasm	-3.7	44.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 378 formula percentile(mortality_count) − percentile(active_trials) activity 63 burdenPercentile 7.4 activityPercentile 11.1 ranking row 2604236
17	▲5	Malignant Hypopharyngeal Neoplasm	-3.7	40.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 96 formula percentile(mortality_count) − percentile(active_trials) activity 53 burdenPercentile 0 activityPercentile 3.7 ranking row 2604237
18	▲5	Malignant Central Nervous System Neoplasm	-7.4	37	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 7430 formula percentile(mortality_count) − percentile(active_trials) activity 823 burdenPercentile 70.4 activityPercentile 77.8 ranking row 2604238
19	=	Malignant Mesothelioma	-7.4	33.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 599 formula percentile(mortality_count) − percentile(active_trials) activity 96 burdenPercentile 18.5 activityPercentile 25.9 ranking row 2604239
20	▲7	Leukemia	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9743 formula percentile(mortality_count) − percentile(active_trials) activity 1769 burdenPercentile 81.5 activityPercentile 88.9 ranking row 2604240
20	▼1	Malignant Liver Neoplasm	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9267 formula percentile(mortality_count) − percentile(active_trials) activity 906 burdenPercentile 77.8 activityPercentile 85.2 ranking row 2604241
22	▲2	Multiple Myeloma	-11.1	22.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5496 formula percentile(mortality_count) − percentile(active_trials) activity 814 burdenPercentile 63 activityPercentile 74.1 ranking row 2604242
23	▲6	Malignant Cervical Neoplasm	-14.9	18.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4152 formula percentile(mortality_count) − percentile(active_trials) activity 505 burdenPercentile 44.4 activityPercentile 59.3 ranking row 2604243
24	▲8	Non-Hodgkin Lymphoma	-18.5	14.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 8792 formula percentile(mortality_count) − percentile(active_trials) activity 2168 burdenPercentile 74.1 activityPercentile 92.6 ranking row 2604244
25	▲6	Malignant Gastric Neoplasm	-18.6	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4470 formula percentile(mortality_count) − percentile(active_trials) activity 652 burdenPercentile 48.1 activityPercentile 66.7 ranking row 2604245
26	▲8	Hodgkin Lymphoma	-22.2	7.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 385 formula percentile(mortality_count) − percentile(active_trials) activity 179 burdenPercentile 11.1 activityPercentile 33.3 ranking row 2604246
27	▲5	Malignant Esophageal Neoplasm	-22.3	3.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3139 formula percentile(mortality_count) − percentile(active_trials) activity 518 burdenPercentile 40.7 activityPercentile 63 ranking row 2604247
28	▲7	Malignant Nasopharyngeal Neoplasm	-37	0	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 191 formula percentile(mortality_count) − percentile(active_trials) activity 261 burdenPercentile 3.7 activityPercentile 40.7 ranking row 2604248

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash e103a43de2696f6f4e64d080

Methodology

How this table was built

Formula: percentile(mortality_count) − percentile(active_trials)
Version: ci-trial-gap-v1
Scope: USA · Female · all ages · 2019 · top-level cancers
Scope key: geo=USA|sex=female|age=all|year=2019|level=top
Eligible entities: 28
Generated: Sep 29, 2026, 06:30 AM UTC
Inputs hash: e103a43de2696f6f4e64d080
Sources: U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality clinicaltrials cdc-wonder seer iarc-globocan
Aggregation: none

Eligibility

requires: mortality_count
active_trials
entityLevel: top

Full methodology · ties share a rank (1, 2, 2, 4) · previous rank refers to the last snapshot of the same scope.

Download CSV (with attribution)

Burden and lethality metrics depend on registry definitions (site groups, standard population, estimate type). Compare only within one table.